12 completed. 12 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 12 |
| Phase 2 | 2 | Completed 2 |
Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Cannabinoids on Appetite in Scleroderma CBD oil, Placebo - Systemic Sclerosis, Malnutrition | Phase 3 | Completed | Khon Kaen University | 30 | 2022-11-09 | 2025-02-20 |
| Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis CO2 Vaginal Laser - Systemic Sclerosis, Vulvovaginal Signs and Symptoms | Phase 2 / Phase 3 | Completed | IRCCS San Raffaele | 16 | 2020-05-01 | 2024-01-30 |
| Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease Mycophenolate mofetil, Placebo - Systemic Sclerosis, Scleroderma | Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 41 | 2016-10-01 | 2018-06-06 |
| A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) Placebo, Tocilizumab - Systemic Sclerosis | Phase 3 | Completed | Hoffmann-La Roche | 212 | 2015-11-20 | 2020-03-09 |
| Gastroesophageal Reflux Treatment in Scleroderma Alginic acid, placebo (for domperidone), Domperidone - Gastroesophageal Reflux Disease, Systemic Sclerosis | Phase 3 | Completed | Khon Kaen University | 80 | 2013-06-01 | 2017-03-27 |
| Rituximab in Systemic Sclerosis Rituximab, Placebo (NaCl) - Systemic Sclerosis | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 22 | 2013-04-09 | 2025-11-20 |
| Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease Cyclophosphamide, Placebo - Systemic Sclerosis, Scleroderma | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 40 | 2013-01-14 | 2025-09-12 |
| Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients macitentan 3mg, macitentan 10mg, placebo - Systemic Sclerosis, Ulcers | Phase 3 | Completed | Actelion | 289 | 2011-12-01 | 2015-01-06 |
| Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension Rosuvastatin - Systemic Sclerosis | Phase 3 | Completed | University of Alexandria | 40 | 2008-09-01 | 2009-09-25 |
| Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma Bosentan 62.5 mg, Bosentan 125 mg, Placebo - Digital Ulcers, Systemic Sclerosis | Phase 3 | Completed | Actelion | 188 | 2003-10-01 | 2025-02-03 |
| Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma Relaxin - Systemic Sclerosis | Phase 3 | Completed | University of Medicine and Dentistry of New Jersey | 231 | 1998-12-01 | 2008-06-25 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis iloprost - Systemic Sclerosis, Raynaud Disease | Phase 3 | Completed | National Center for Research Resources (NCRR) | 200 | 1995-12-01 | 2005-06-24 |
Scleroderma, Systemic (12) · Scleroderma, Diffuse (7) · Arthritis (2) · Lung Diseases, Interstitial (2) · Pulmonary Fibrosis (2) · digital ulcers (2) · Anorexia (1) · Connective Tissue Diseases (1) · Gastroesophageal Reflux (1) · Hypertension, Pulmonary (1) · Malnutrition (1) · Rare Diseases (1) · Raynaud Disease (1) · Respiratory Tract Diseases (1) · Sexual Dysfunctions, Psychological (1)
Skin Diseases (12) · Skin and Connective Tissue Diseases (12) · Connective Tissue Diseases (11) · Pathological Conditions, Signs and Symptoms (5) · Lung Diseases (4) · Pathologic Processes (4) · Respiratory Tract Diseases (4) · Cardiovascular Diseases (2) · Fibrosis (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Vascular Diseases (2) · Deglutition Disorders (1) · Digestive System Diseases (1) · Disease Attributes (1)
Alginic Acid (1) · Bosentan (1) · Cyclophosphamide (1) · Domperidone (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Iloprost (1) · Mycophenolic Acid (1) · Relaxin (1) · Rituximab (1) · Rosuvastatin Calcium (1) · macitentan (1) · tocilizumab (1)
Actelion (2) · Assistance Publique - Hôpitaux de Paris (2) · Khon Kaen University (2) · Hoffmann-La Roche (1) · IRCCS San Raffaele (1) · National Center for Research Resources (NCRR) (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · University of Alexandria (1) · University of Medicine and Dentistry of New Jersey (1)
France (3) · Italy (3) · Bulgaria (2) · Canada (2) · Denmark (2) · Germany (2) · Hungary (2) · India (2) · Poland (2) · Thailand (2) · United States (2) · Argentina (1) · Australia (1) · Belarus (1) · Belgium (1)
Anna Abou-Raya (1) · Chingching Foocharoen, M.D. (1) · Chingching Foocharoen, MD (1) · James Seibold, MD (1) · Luc Mouthon, MD, PhD (1) · Thomas A. Medsger, Jr. (1) · Yannick Allanore, MD, PhD (1)
PMID 20805294, PMID 27163986, PMID 27179107, PMID 31813058, PMID 32866440, PMID 33294861, PMID 33538094, PMID 33765691, PMID 34851799, PMID 37228011, PMID 41137182
2015 (1)